
    
      This study starts at admission of the patient on the ICU. In the next 24 hours the patient
      receives nitro-glycerine or placebo (randomised). At time = 0, Â½, 2, 12 and 24 hour we
      evaluate the microcirculation by SDF imaging and monitoring of hemodynamic parameters.

      Informed consent is obtained of the relatives.
    
  